Bioengineering a Light-Responsive Encapsulin Nanoreactor: A Potential Tool for <i>In Vitro</i> Photodynamic Therapy.
- Publisher:
- AMER CHEMICAL SOC
- Publication Type:
- Journal Article
- Citation:
- ACS applied materials & interfaces, 2021, 13, (7), pp. 7977-7986
- Issue Date:
- 2021-02-15
Closed Access
Filename | Description | Size | |||
---|---|---|---|---|---|
acsami.0c21141.pdf | Published version | 3.49 MB |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Diaz, D | |
dc.contributor.author | Vidal, X | |
dc.contributor.author | Sunna, A | |
dc.contributor.author |
Care, A |
|
dc.date.accessioned | 2021-09-15T22:41:01Z | |
dc.date.available | 2021-09-15T22:41:01Z | |
dc.date.issued | 2021-02-15 | |
dc.identifier.citation | ACS applied materials & interfaces, 2021, 13, (7), pp. 7977-7986 | |
dc.identifier.issn | 1944-8244 | |
dc.identifier.issn | 1944-8252 | |
dc.identifier.uri | http://hdl.handle.net/10453/150570 | |
dc.description.abstract | Encapsulins, a prokaryotic class of self-assembling protein nanocompartments, are being re-engineered to serve as "nanoreactors" for the augmentation or creation of key biochemical reactions. However, approaches that allow encapsulin nanoreactors to be functionally activated with spatial and temporal precision are lacking. We report the construction of a light-responsive encapsulin nanoreactor for "on demand" production of reactive oxygen species (ROS). Herein, encapsulins were loaded with the fluorescent flavoprotein mini-singlet oxygen generator (miniSOG), a biological photosensitizer that is activated by blue light to generate ROS, primarily singlet oxygen (<sup>1</sup>O<sub>2</sub>). We established that the nanocompartments stably encased miniSOG and in response to blue light were able to mediate the photoconversion of molecular oxygen into ROS. Using an <i>in vitro</i> model of lung cancer, we showed that ROS generated by the nanoreactor triggered photosensitized oxidation reactions which exerted a toxic effect on tumor cells, suggesting utility in photodynamic therapy. This encapsulin nanoreactor thus represents a platform for the light-controlled initiation and/or modulation of ROS-driven processes in biomedicine and biotechnology. | |
dc.format | Print-Electronic | |
dc.language | eng | |
dc.publisher | AMER CHEMICAL SOC | |
dc.relation | http://purl.org/au-research/grants/arc/CE140100003 | |
dc.relation.ispartof | ACS applied materials & interfaces | |
dc.relation.isbasedon | 10.1021/acsami.0c21141 | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | 03 Chemical Sciences, 09 Engineering | |
dc.subject.classification | Nanoscience & Nanotechnology | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Lung Neoplasms | |
dc.subject.mesh | Singlet Oxygen | |
dc.subject.mesh | Reactive Oxygen Species | |
dc.subject.mesh | Flavoproteins | |
dc.subject.mesh | Antineoplastic Agents | |
dc.subject.mesh | Photosensitizing Agents | |
dc.subject.mesh | Fluorescent Dyes | |
dc.subject.mesh | Photochemotherapy | |
dc.subject.mesh | Spectrometry, Fluorescence | |
dc.subject.mesh | Drug Screening Assays, Antitumor | |
dc.subject.mesh | Biomedical Engineering | |
dc.subject.mesh | Cell Proliferation | |
dc.subject.mesh | Cell Survival | |
dc.subject.mesh | Particle Size | |
dc.subject.mesh | Surface Properties | |
dc.subject.mesh | Light | |
dc.subject.mesh | Nanocomposites | |
dc.subject.mesh | A549 Cells | |
dc.subject.mesh | A549 Cells | |
dc.subject.mesh | Antineoplastic Agents | |
dc.subject.mesh | Biomedical Engineering | |
dc.subject.mesh | Cell Proliferation | |
dc.subject.mesh | Cell Survival | |
dc.subject.mesh | Drug Screening Assays, Antitumor | |
dc.subject.mesh | Flavoproteins | |
dc.subject.mesh | Fluorescent Dyes | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Light | |
dc.subject.mesh | Lung Neoplasms | |
dc.subject.mesh | Nanocomposites | |
dc.subject.mesh | Particle Size | |
dc.subject.mesh | Photochemotherapy | |
dc.subject.mesh | Photosensitizing Agents | |
dc.subject.mesh | Reactive Oxygen Species | |
dc.subject.mesh | Singlet Oxygen | |
dc.subject.mesh | Spectrometry, Fluorescence | |
dc.subject.mesh | Surface Properties | |
dc.title | Bioengineering a Light-Responsive Encapsulin Nanoreactor: A Potential Tool for <i>In Vitro</i> Photodynamic Therapy. | |
dc.type | Journal Article | |
utslib.citation.volume | 13 | |
utslib.location.activity | United States | |
utslib.for | 03 Chemical Sciences | |
utslib.for | 09 Engineering | |
pubs.organisational-group | /University of Technology Sydney | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Science | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Science/School of Life Sciences | |
utslib.copyright.status | closed_access | * |
dc.date.updated | 2021-09-15T22:40:58Z | |
pubs.issue | 7 | |
pubs.publication-status | Published | |
pubs.volume | 13 | |
utslib.citation.issue | 7 |
Abstract:
Encapsulins, a prokaryotic class of self-assembling protein nanocompartments, are being re-engineered to serve as "nanoreactors" for the augmentation or creation of key biochemical reactions. However, approaches that allow encapsulin nanoreactors to be functionally activated with spatial and temporal precision are lacking. We report the construction of a light-responsive encapsulin nanoreactor for "on demand" production of reactive oxygen species (ROS). Herein, encapsulins were loaded with the fluorescent flavoprotein mini-singlet oxygen generator (miniSOG), a biological photosensitizer that is activated by blue light to generate ROS, primarily singlet oxygen (1O2). We established that the nanocompartments stably encased miniSOG and in response to blue light were able to mediate the photoconversion of molecular oxygen into ROS. Using an in vitro model of lung cancer, we showed that ROS generated by the nanoreactor triggered photosensitized oxidation reactions which exerted a toxic effect on tumor cells, suggesting utility in photodynamic therapy. This encapsulin nanoreactor thus represents a platform for the light-controlled initiation and/or modulation of ROS-driven processes in biomedicine and biotechnology.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph